2013
National psychotropic prescription dispensation among dually diagnosed patients
Marienfeld C, Rosenheck R. National psychotropic prescription dispensation among dually diagnosed patients. Advances In Dual Diagnosis 2013, 6: 34-44. DOI: 10.1108/17570971311309015.Peer-Reviewed Original ResearchAnalysis of covarianceNational Veterans Health AdministrationOutpatient mental health visitsMental health service useMental health visitsHealth service useVeterans Health AdministrationSevere mental illnessDrug-drug interactionsSchizophrenia spectrum disordersPrescription dispensationMedication classesClinic visitsClinical confoundersPharmacy recordsHealth visitsPsychotropic prescriptionsMood stabilizersPsychotropic medicationsMore prescriptionsHigh riskPatientsService useHealth AdministrationBipolar disorder
2006
Special Section on CATIE Baseline Data: Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial
Chakos M, Glick I, Miller A, Hamner M, Miller D, Patel J, Tapp A, Keefe R, Rosenheck R. Special Section on CATIE Baseline Data: Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial. Psychiatric Services 2006, 57: 1094-1101. PMID: 16870959, DOI: 10.1176/ps.2006.57.8.1094.Peer-Reviewed Original ResearchConceptsConcomitant psychotropic medicationsPsychotropic medicationsConcomitant medication useIntervention Effectiveness (CATIE) trialOnly partial responseSecond-generation antipsychoticsBetter neurocognitive functioningClinical Antipsychotic TrialsPartial responseCATIE trialMedication useAnticholinergic drugsBaseline useMedication dataMood stabilizersCases symptomsConcomitant useEffectiveness trialAntipsychotic TrialsMedicationsNeurocognitive functioningSchizophreniaBaseline dataTrialsAntipsychotics